Cable Hill Partners LLC Acquires Shares of 1,424 Agilent Technologies, Inc. (NYSE:A)

Cable Hill Partners LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,424 shares of the medical research company’s stock, valued at approximately $211,000.

Several other hedge funds and other institutional investors have also modified their holdings of A. Livelsberger Financial Advisory acquired a new stake in Agilent Technologies in the 3rd quarter valued at about $28,000. Crewe Advisors LLC raised its position in Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in Agilent Technologies during the 3rd quarter worth $31,000. Ridgewood Investments LLC bought a new position in Agilent Technologies in the 2nd quarter valued at $29,000. Finally, Fortitude Family Office LLC raised its position in shares of Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after acquiring an additional 95 shares during the last quarter. Institutional investors own 87.42% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on A. Bank of America raised their price target on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. UBS Group upped their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Barclays boosted their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a report on Tuesday, October 15th. TD Cowen increased their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Finally, Citigroup raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $144.36.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 19.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This trade represents a 7.51 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,995 shares of company stock valued at $1,739,510 in the last ninety days. 0.33% of the stock is currently owned by corporate insiders.

Agilent Technologies Stock Performance

Shares of A stock opened at $130.22 on Friday. The company has a fifty day moving average price of $139.09 and a two-hundred day moving average price of $138.14. Agilent Technologies, Inc. has a one year low of $111.33 and a one year high of $155.35. The stock has a market cap of $37.42 billion, a P/E ratio of 27.02, a P/E/G ratio of 5.88 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.43 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were issued a dividend of $0.236 per share. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 annualized dividend and a yield of 0.72%. Agilent Technologies’s payout ratio is currently 19.50%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.